The global Chemotherapy Induced Peripheral Neuropathy market continues to attract attention as the need for managing chemotherapy-associated complications becomes more prominent in cancer care. O...
Chemotherapy-induced neutropenia remains one of the most common complications associated with cancer treatment, creating significant challenges for patients and healthcare providers. The growing ...
Chemotherapy-induced thrombocytopenia (CIT) is a common adverse effect of cancer treatment that results in reduced platelet counts, increasing the risk of bleeding and treatment delays. The growi...
Chemotherapy-Induced Peripheral Neuropathy (CIPN) is one of the most common and challenging side effects associated with cancer therapy, affecting patients' quality of life and treatment outcomes...
